Detected ·
ai3Bio
$48M—
ai3Bio launched with a $48M Series A co-led by UPMC Enterprises and Ziff Capital Partners to advance its Th17 cell-targeting platforms toward first-in-human trials.
- Website
- ai3.bio
- linkedin.com/company/ai3-bio
- Amount
- $48 000 000 USD
- Stage
- —
- Event
- Funding round
- Detected
- 2026-10-02 00:02:09 UTC
- Signal ID
- e45fb6b0-d847-46dc-bb03-8b802c988b0b
As the API returns it
{
"id": "e45fb6b0-d847-46dc-bb03-8b802c988b0b",
"created_at": "2026-10-02T00:02:09.814861Z",
"company_name": "ai3Bio",
"company_website_url": "ai3.bio",
"company_linkedin_url": "https://www.linkedin.com/company/ai3-bio",
"event_type": "funding",
"funding_amount": 48000000,
"funding_currency": "USD",
"funding_stage": null,
"message": "*ai3Bio launched with a $48M Series A co-led by UPMC Enterprises and Ziff Capital Partners to advance its Th17 cell-targeting platforms toward first-in-human trials.*"
}